{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:05:27Z","timestamp":1787839527000,"version":"build-2784847793"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T00:00:00Z","timestamp":1717459200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01-CA27467701"],"award-info":[{"award-number":["R01-CA27467701"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioactive Materials"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.bioactmat.2024.06.008","type":"journal-article","created":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T17:04:56Z","timestamp":1721754296000},"page":"557-570","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Gelatin and lipidoid integrate to create gelasomes to enhance siRNA delivery with low toxicity"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9633-6219","authenticated-orcid":false,"given":"Abilash","family":"Gangula","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhananjay","family":"Suresh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agasthya Suresh","family":"Babu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anandhi","family":"Upendran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghuraman","family":"Kannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bioactmat.2024.06.008_bib1","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12943-017-0683-y","article-title":"Nano-based delivery of RNAi in cancer therapy","volume":"16","author":"Xin","year":"2017","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bioactmat.2024.06.008_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114113","article-title":"RNAi-based therapeutics and tumor targeted delivery in cancer","volume":"182","author":"Kara","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.bioactmat.2024.06.008_bib3","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.mam.2006.12.004","article-title":"RNA interference: implications for cancer treatment","volume":"28","author":"Masiero","year":"2007","journal-title":"Mol. Aspect. Med."},{"key":"10.1016\/j.bioactmat.2024.06.008_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.644718","article-title":"Insight into the Prospects for RNAi therapy of cancer","volume":"12","author":"Tian","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.bioactmat.2024.06.008_bib5","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/nrd2742","article-title":"Knocking down barriers: advances in siRNA delivery","volume":"8","author":"Whitehead","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"issue":"2","key":"10.1016\/j.bioactmat.2024.06.008_bib6","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ymthe.2024.01.005","article-title":"The Landscape of nanoparticle-based siRNA delivery and therapeutic Development","volume":"32","author":"Moazzam","year":"2024","journal-title":"Mol. Ther."},{"issue":"10","key":"10.1016\/j.bioactmat.2024.06.008_bib7","doi-asserted-by":"crossref","first-page":"731","DOI":"10.3109\/10611860903096540","article-title":"Gelatin-based delivery systems for cancer gene therapy","volume":"17","author":"Nezhadi","year":"2009","journal-title":"J. Drug Target."},{"issue":"1","key":"10.1016\/j.bioactmat.2024.06.008_bib8","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ijpharm.2011.05.036","article-title":"Non-condensing polymeric nanoparticles for targeted gene and siRNA delivery","volume":"427","author":"Xu","year":"2012","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.bioactmat.2024.06.008_bib9","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1073\/pnas.0910603106","article-title":"Lipid-like materials for low-dose, in vivo gene silencing","volume":"107","author":"Love","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"49","key":"10.1016\/j.bioactmat.2024.06.008_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201903637","article-title":"Rekindling RNAi therapy: materials design Requirements for in vivo siRNA delivery","volume":"31","author":"Kim","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bioactmat.2024.06.008_bib11","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ijbiomac.2015.08.006","article-title":"Recent advancement of gelatin nanoparticles in drug and vaccine delivery","volume":"81","author":"Sahoo","year":"2015","journal-title":"Int. J. Biol. Macromol."},{"issue":"9","key":"10.1016\/j.bioactmat.2024.06.008_bib12","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1517\/17425247.2015.1037272","article-title":"Drug delivery from gelatin-based systems","volume":"12","author":"Foox","year":"2015","journal-title":"Expet Opin. Drug Deliv."},{"key":"10.1016\/j.bioactmat.2024.06.008_bib13","series-title":"Biopolymer-Based Nanomaterials in Drug Delivery and Biomedical Applications","first-page":"407","article-title":"Gelatin-based nanomaterials in drug delivery and biomedical applications","author":"Parashar","year":"2021"},{"issue":"4","key":"10.1016\/j.bioactmat.2024.06.008_bib14","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1081\/FRI-120025483","article-title":"Gelatin: the paramount food additive","volume":"19","author":"Baziwane","year":"2003","journal-title":"Food Rev. Int."},{"issue":"2","key":"10.1016\/j.bioactmat.2024.06.008_bib15","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1002\/jbm.b.31366","article-title":"Novel drug\u2010loaded gelatin films and their sustained\u2010release performance","volume":"90B","author":"Lin","year":"2009","journal-title":"J. Biomed. Mater. Res. B Appl. Biomater."},{"key":"10.1016\/j.bioactmat.2024.06.008_bib16","series-title":"Nanotechnologies for the Life Sciences","article-title":"Gelatin nanoparticles and their biofunctionalization","author":"Kommareddy","year":"2003"},{"key":"10.1016\/j.bioactmat.2024.06.008_bib17","series-title":"Polymeric Nanoparticles as a Promising Tool for Anti-cancer Therapeutics","first-page":"319","article-title":"Animal-based materials in the formulation of nanocarriers for anticancer therapeutics","author":"Babu","year":"2019"},{"key":"10.1016\/j.bioactmat.2024.06.008_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2021.117768","article-title":"Chitosan hydrogels in 3D printing for biomedical applications","volume":"260","author":"Rajabi","year":"2021","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.bioactmat.2024.06.008_bib19","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3389\/fbioe.2020.00437","article-title":"Strategies to obtain encapsulation and controlled release of small hydrophilic molecules","volume":"8","author":"Li","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"3","key":"10.1016\/j.bioactmat.2024.06.008_bib20","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1021\/acsomega.9b03487","article-title":"Prediction of drug loading in the gelatin matrix using computational methods","volume":"5","author":"Hathout","year":"2020","journal-title":"ACS Omega"},{"key":"10.1016\/j.bioactmat.2024.06.008_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.nano.2019.04.010","article-title":"Silencing AXL by covalent siRNA-gelatin-antibody nanoconjugate inactivates mTOR\/EMT pathway and stimulates P53 for TKI sensitization in NSCLC","volume":"20","author":"Suresh","year":"2019","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"1","key":"10.1016\/j.bioactmat.2024.06.008_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/srep30245","article-title":"Targeted nanoconjugate Co-delivering siRNA and tyrosine kinase inhibitor to KRAS mutant NSCLC dissociates GAB1-SHP2 post oncogene knockdown","volume":"6","author":"Srikar","year":"2016","journal-title":"Sci. Rep."},{"issue":"16","key":"10.1016\/j.bioactmat.2024.06.008_bib23","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1080\/09205063.2021.1958183","article-title":"Intracellular controlled release prolongs the time period of siRNA-based gene suppression","volume":"32","author":"Chujo","year":"2021","journal-title":"J. Biomater. Sci. Polym. Ed."},{"issue":"8","key":"10.1016\/j.bioactmat.2024.06.008_bib24","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1039\/C9CC09068A","article-title":"Stiffness of cationized gelatin nanoparticles is a key factor determining RNAi efficiency in myeloid leukemia cells","volume":"56","author":"Zhang","year":"2020","journal-title":"Chem. Commun."},{"issue":"1","key":"10.1016\/j.bioactmat.2024.06.008_bib25","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jconrel.2011.10.035","article-title":"Polyethyleneimine-based core-shell nanogels: a promising siRNA carrier for argininosuccinate synthetase mRNA knockdown in HeLa cells","volume":"158","author":"Mimi","year":"2012","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.bioactmat.2024.06.008_bib26","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cej.2017.12.114","article-title":"Efficient EFGR mediated siRNA delivery to breast cancer cells by cetuximab functionalized Pluronic\u00ae F127\/gelatin","volume":"340","author":"Rafael","year":"2018","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.bioactmat.2024.06.008_bib27","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.colsurfb.2015.08.008","article-title":"Comparison of different cationized proteins as biomaterials for nanoparticle-based ocular gene delivery","volume":"135","author":"Zorzi","year":"2015","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"35","key":"10.1016\/j.bioactmat.2024.06.008_bib28","doi-asserted-by":"crossref","first-page":"9097","DOI":"10.1016\/j.biomaterials.2012.08.032","article-title":"Gelatin nanospheres incorporating siRNA for controlled intracellular release","volume":"33","author":"Ishikawa","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioactmat.2024.06.008_bib29","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.colsurfb.2016.05.066","article-title":"Silencing of the metastasis-linked gene, AEG-1, using siRNA-loaded cholamine surface-modified gelatin nanoparticles in the breast carcinoma cell line MCF-7","volume":"145","author":"Abozeid","year":"2016","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"1","key":"10.1016\/j.bioactmat.2024.06.008_bib30","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/s41598-020-80542-4","article-title":"Positive-charge tuned gelatin hydrogel-siSPARC injectable for siRNA anti-scarring therapy in post glaucoma filtration surgery","volume":"11","author":"Chun","year":"2021","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.bioactmat.2024.06.008_bib31","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/cpr.12192","article-title":"Independent effect of polymeric nanoparticle zeta potential\/surface charge, on their cytotoxicity and affinity to cells","volume":"48","author":"Shao","year":"2015","journal-title":"Cell Prolif."},{"issue":"1","key":"10.1016\/j.bioactmat.2024.06.008_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0245899","article-title":"Complexation design of cationized gelatin and molecular beacon to visualize intracellular mRNA","volume":"16","author":"Takehana","year":"2021","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bioactmat.2024.06.008_bib33","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jconrel.2006.04.014","article-title":"Toxicity of cationic lipids and cationic polymers in gene delivery","volume":"114","author":"Lv","year":"2006","journal-title":"J. Contr. Release"},{"issue":"2\u20133","key":"10.1016\/j.bioactmat.2024.06.008_bib34","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.addr.2007.03.010","article-title":"Toxicogenomics of non-viral drug delivery systems for RNAi: potential impact on siRNA-mediated gene silencing activity and specificity","volume":"59","author":"Akhtar","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/j.bioactmat.2024.06.008_bib35","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/cr.2015.9","article-title":"Cationic nanocarriers induce cell necrosis through impairment of Na+\/K+-ATPase and cause subsequent inflammatory response","volume":"25","author":"Wei","year":"2015","journal-title":"Cell Res."},{"issue":"3","key":"10.1016\/j.bioactmat.2024.06.008_bib36","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1039\/C8TX00005K","article-title":"Correlation of the cytotoxic effects of cationic lipids with their headgroups","volume":"7","author":"Cui","year":"2018","journal-title":"Toxicol. Res."},{"issue":"9","key":"10.1016\/j.bioactmat.2024.06.008_bib37","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1038\/mt.2011.141","article-title":"Synergistic silencing: combinations of lipid-like materials for efficacious siRNA delivery","volume":"19","author":"Whitehead","year":"2011","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.bioactmat.2024.06.008_bib38","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1038\/ncomms5277","article-title":"Degradable lipid nanoparticles with predictable in vivo siRNA delivery activity","volume":"5","author":"Whitehead","year":"2014","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.bioactmat.2024.06.008_bib39","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nbt1402","article-title":"A combinatorial library of lipid-like materials for delivery of RNAi therapeutics","volume":"26","author":"Akinc","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bioactmat.2024.06.008_bib40","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.chemphyslip.2017.07.002","article-title":"Gelatin modified lipid nanoparticles for anti- viral drug delivery","volume":"207","author":"K","year":"2017","journal-title":"Chem. Phys. Lipids"},{"issue":"7","key":"10.1016\/j.bioactmat.2024.06.008_bib41","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1111\/1750-3841.16221","article-title":"Peppermint essential oil\u2010loaded solid lipid nanoparticle in gelatin coating: characterization and antibacterial activity against foodborne pathogen inoculated on rainbow trout (Oncorhynchus mykiss) fillet during refrigerated storage","volume":"87","author":"Laein","year":"2022","journal-title":"J. Food Sci."},{"key":"10.1016\/j.bioactmat.2024.06.008_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.lwt.2022.113265","article-title":"Development of heat-stable gelatin-coated nanostructured lipid carriers (NLC): colloidal and stability properties","volume":"160","author":"Sahraee","year":"2022","journal-title":"Lebensm. Wiss. Technol."},{"issue":"4","key":"10.1016\/j.bioactmat.2024.06.008_bib43","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.3390\/molecules27041372","article-title":"A review of liposomes as a drug delivery system: current status of approved products, regulatory environments, and future perspectives","volume":"27","author":"Liu","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bioactmat.2024.06.008_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120571","article-title":"Design of liposomes as drug delivery system for therapeutic applications","volume":"601","author":"Guimar\u00e3es","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioactmat.2024.06.008_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2015.00286","article-title":"Advances and challenges of liposome assisted drug delivery","volume":"6","author":"Sercombe","year":"2015","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.bioactmat.2024.06.008_bib46","doi-asserted-by":"crossref","first-page":"782","DOI":"10.3390\/polym15030782","article-title":"Coating materials to increase the stability of liposomes","volume":"15","author":"Pasarin","year":"2023","journal-title":"Polymers"},{"issue":"2","key":"10.1016\/j.bioactmat.2024.06.008_bib47","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3390\/nano10020190","article-title":"Immunological and toxicological considerations for the design of liposomes","volume":"10","author":"Inglut","year":"2020","journal-title":"Nanomaterials"},{"issue":"46","key":"10.1016\/j.bioactmat.2024.06.008_bib48","doi-asserted-by":"crossref","first-page":"18638","DOI":"10.1073\/pnas.1303958110","article-title":"Enhancing tumor cell response to chemotherapy through nanoparticle-mediated codelivery of siRNA and cisplatin prodrug","volume":"110","author":"Xu","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.bioactmat.2024.06.008_bib49","doi-asserted-by":"crossref","first-page":"466","DOI":"10.3390\/cancers14030466","article-title":"AXL receptor tyrosine kinase as a promising therapeutic target directing multiple aspects of cancer progression and metastasis","volume":"14","author":"Goyette","year":"2022","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.bioactmat.2024.06.008_bib50","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12951-021-00896-3","article-title":"Protein nanoparticles in drug delivery: animal protein, plant proteins and protein cages, albumin nanoparticles","volume":"19","author":"Kianfar","year":"2021","journal-title":"J. Nanobiotechnol."},{"issue":"8","key":"10.1016\/j.bioactmat.2024.06.008_bib51","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1016\/j.foodhyd.2011.02.007","article-title":"Functional and bioactive properties of collagen and gelatin from alternative sources: a review","volume":"25","author":"G\u00f3mez-Guill\u00e9n","year":"2011","journal-title":"Food Hydrocolloids"},{"issue":"23","key":"10.1016\/j.bioactmat.2024.06.008_bib52","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.3390\/polym13234078","article-title":"Highly efficient synthesis of type B gelatin and low molecular weight chitosan nanoparticles: potential applications as bioactive molecule carriers and cell-penetrating agents","volume":"13","author":"Gonzalez-Melo","year":"2021","journal-title":"Polymers"},{"issue":"4","key":"10.1016\/j.bioactmat.2024.06.008_bib53","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.3390\/polym15041026","article-title":"Gelatin-based hydrogels: potential biomaterials for remediation","volume":"15","author":"Andreazza","year":"2023","journal-title":"Polymers"},{"key":"10.1016\/j.bioactmat.2024.06.008_bib54","article-title":"The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles","volume":"5577","author":"Fr\u00f6hlich","year":"2012","journal-title":"Int. J. Nanomed."},{"issue":"6","key":"10.1016\/j.bioactmat.2024.06.008_bib55","doi-asserted-by":"crossref","first-page":"877","DOI":"10.3390\/pharmaceutics13060877","article-title":"Protamine-based strategies for RNA transfection","volume":"13","author":"Jarzebska","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bioactmat.2024.06.008_bib56","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.apmt.2018.05.002","article-title":"PAMAM dendrimers as efficient drug and gene delivery nanosystems for cancer therapy","volume":"12","author":"Abedi-Gaballu","year":"2018","journal-title":"Appl. Mater. Today"},{"issue":"7","key":"10.1016\/j.bioactmat.2024.06.008_bib57","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/acs.accounts.9b00177","article-title":"Carriers break barriers in drug delivery: endocytosis and endosomal escape of gene delivery vectors","volume":"52","author":"Degors","year":"2019","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.bioactmat.2024.06.008_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174178","article-title":"siRNA: mechanism of action, challenges, and therapeutic approaches","volume":"905","author":"Alshaer","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bioactmat.2024.06.008_bib59","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jconrel.2018.06.017","article-title":"Neutralization of negative charges of siRNA results in improved safety and efficient gene silencing activity of lipid nanoparticles loaded with high levels of siRNA","volume":"284","author":"Sato","year":"2018","journal-title":"J. Contr. Release"},{"issue":"1","key":"10.1016\/j.bioactmat.2024.06.008_bib60","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/mt.2009.208","article-title":"Evaluation of efficacy, biodistribution, and inflammation for a potent siRNA nanoparticle: effect of dexamethasone Co-treatment","volume":"18","author":"Abrams","year":"2010","journal-title":"Mol. Ther."},{"issue":"3","key":"10.1016\/j.bioactmat.2024.06.008_bib61","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/mt.2010.282","article-title":"Mechanistically probing lipid-siRNA nanoparticle-associated toxicities identifies jak inhibitors effective in mitigating multifaceted toxic responses","volume":"19","author":"Tao","year":"2011","journal-title":"Mol. Ther."},{"issue":"15","key":"10.1016\/j.bioactmat.2024.06.008_bib62","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1016\/j.addr.2012.06.007","article-title":"Safety profile of RNAi nanomedicines","volume":"64","author":"Barros","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioactmat.2024.06.008_bib63","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jconrel.2017.09.044","article-title":"Highly specific delivery of siRNA to hepatocytes circumvents endothelial cell-mediated lipid nanoparticle-associated toxicity leading to the safe and efficacious decrease in the hepatitis B virus","volume":"266","author":"Sato","year":"2017","journal-title":"J. Contr. Release"},{"issue":"1","key":"10.1016\/j.bioactmat.2024.06.008_bib64","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.drudis.2016.09.024","article-title":"In vivo fate of lipid-based nanoparticles","volume":"22","author":"Qi","year":"2017","journal-title":"Drug Discov. Today"},{"issue":"8","key":"10.1016\/j.bioactmat.2024.06.008_bib65","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1038\/mt.2013.124","article-title":"Biodegradable lipids enabling rapidly eliminated lipid nanoparticles for systemic delivery of RNAi therapeutics","volume":"21","author":"Maier","year":"2013","journal-title":"Mol. Ther."},{"issue":"6","key":"10.1016\/j.bioactmat.2024.06.008_bib66","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1517\/17425247.2016.1167035","article-title":"Strategies for improving the intratumoral distribution of liposomal drugs in cancer therapy","volume":"13","author":"Goins","year":"2016","journal-title":"Expet Opin. Drug Deliv."},{"issue":"5","key":"10.1016\/j.bioactmat.2024.06.008_bib67","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s002590000380","article-title":"The potential of intratumoural unsealed radioactive source therapy","volume":"28","author":"McCready","year":"2001","journal-title":"Eur. J. Nucl. Med."},{"issue":"11","key":"10.1016\/j.bioactmat.2024.06.008_bib68","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1200\/JCO.2008.17.7188","article-title":"DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer","volume":"27","author":"Iacobuzio-Donahue","year":"2009","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"issue":"22","key":"10.1016\/j.bioactmat.2024.06.008_bib69","first-page":"6712","article-title":"Systemic gene therapy in human xenograft tumor models by liposomal delivery of the E1A gene","volume":"62","author":"Ueno","year":"2002","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.bioactmat.2024.06.008_bib70","first-page":"1237","article-title":"Phase I trial of intratumoral liposome E1A gene therapy in patients with recurrent breast and head and neck cancer","volume":"7","author":"Yoo","year":"2001","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."}],"container-title":["Bioactive Materials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452199X24002202?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452199X24002202?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T15:58:17Z","timestamp":1751385497000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452199X24002202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":70,"alternative-id":["S2452199X24002202"],"URL":"https:\/\/doi.org\/10.1016\/j.bioactmat.2024.06.008","relation":{},"ISSN":["2452-199X"],"issn-type":[{"value":"2452-199X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gelatin and lipidoid integrate to create gelasomes to enhance siRNA delivery with low toxicity","name":"articletitle","label":"Article Title"},{"value":"Bioactive Materials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioactmat.2024.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}